BL-918 is an orally active UNC-51-like kinase 1 (ULK1) activator with an EC50 of 24.14 nM. BL-918 exerts its cytoprotective autophagic effect by targeting ULK complex. BL-918 has the potential for Parkinsons disease (PD) treatment[1].
Molecular Weight:
533.44
Purity:
99.72
CAS Number:
[2101517-69-3]
Formula:
C23H15F8N3OS
Target:
Autophagy,ULK
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted